StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) stock

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$4.52−0.33 (-6.80%)

Close on Nov 17, 2026Market cap $284.05MP/E –Yield –

Cytosorbents market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cytosorbents's market cap was $335.58M on Nov 11, 2026, against $1.02B a year earlier. Over the last 5 years it ranged from $245.09M to $3.64B, with a median of $1.14B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$335.58M-58.2%
2025Dec 31, 2025$802.76M-19.1%
2024Dec 31, 2024$991.91M+1.9%
2023Dec 29, 2023$973.50M-28.0%
2022Dec 30, 2022$1.35B-62.9%
2021Dec 31, 2021$3.64B-47.1%
2020Dec 31, 2020$6.88B+175.7%
2019Dec 31, 2019$2.50B-51.2%
2018Dec 31, 2018$5.11B+38.1%
2017Dec 29, 2017$3.70B+33.4%
2016Dec 30, 2016$2.78B-1.0%
2015Dec 31, 2015$2.80B+9.2%
2014Dec 31, 2014$2.57B+319.2%
2013Dec 31, 2013$612.85M+12.3%
2012Dec 31, 2012$545.73M-1.0%
2011Dec 30, 2011$551.31M–

More Cytosorbents figures

See a number that looks wrong?